HERON THERAPEUTICS, INC. /DE/ Financial Ratios
HRTX|FY2017 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2017 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2017)
Return on Equity
-82.6%
Profit Margin
-7630.3%
Net Income / Revenue
Asset Turnover
0.01
Revenue / Total Assets
Equity Multiplier
1.98
Total Assets / Equity
Composite: -82.6% (reported: -82.6%)
Profitability
Liquidity
Current Ratio
2.21
Quick Ratio
2.11
Solvency
Interest Coverage
-81.97
Efficiency
Asset Turnover
0.01
Inventory Turnover
0.00
Days Sales Outstanding
11950 days
As of FY2017 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-12.6%
+11.2pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.